1,199
Views
14
CrossRef citations to date
0
Altmetric
Report

NEDD4 is involved in acquisition of epithelial-mesenchymal transition in cisplatin-resistant nasopharyngeal carcinoma cells

, , , , , & show all
Pages 869-878 | Received 03 Feb 2017, Accepted 15 Mar 2017, Published online: 20 Apr 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yu Guo, Lichang Yang, Shaorong Lei, Wuyuan Tan & Jianhong Long. (2019) NEDD4 Negatively Regulates GITR via Ubiquitination in Immune Microenvironment of Melanoma. OncoTargets and Therapy 12, pages 10629-10637.
Read now
Wu Wen, Jingying Li, Longwang Wang, Yifei Xing, Xuechao Li, Hailong Ruan, Xiaoqing Xi, Jianhua Xiong & Renrui Kuang. (2017) Inhibition of NEDD4 inhibits cell growth and invasion and induces cell apoptosis in bladder cancer cells. Cell Cycle 16:16, pages 1509-1514.
Read now

Articles from other publishers (12)

Zijian Zhou, Kaifeng Zheng, Shao Zhou, Youxiong Yang, Jun Chen & Xiaofeng Jin. (2023) E3 ubiquitin ligases in nasopharyngeal carcinoma and implications for therapies. Journal of Molecular Medicine 101:12, pages 1543-1565.
Crossref
Kai Lin, Endi Zhou, Ting Shi, Siqing Zhang, Jinfan Zhang, Ziruo Zheng, Yuetian Pan, Wentao Gao & Yabin Yu. (2023) m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway. Journal of Experimental & Clinical Cancer Research 42:1.
Crossref
Sujitha Jayaprakash, Mangala Hegde, Bandari BharathwajChetty, Sosmitha Girisa, Mohammed S. Alqahtani, Mohamed Abbas, Gautam Sethi & Ajaikumar B. Kunnumakkara. (2022) Unraveling the Potential Role of NEDD4-like E3 Ligases in Cancer. International Journal of Molecular Sciences 23:20, pages 12380.
Crossref
Yuanqi Liu, Chaojun Duan & Chunfang Zhang. (2021) E3 Ubiquitin Ligase in Anticancer Drugdsla Resistance: Recent Advances and Future Potential. Frontiers in Pharmacology 12.
Crossref
Sandra Ortiz-Cuaran, Jebrane Bouaoud, Andy Karabajakian, Jérôme Fayette & Pierre Saintigny. (2021) Precision Medicine Approaches to Overcome Resistance to Therapy in Head and Neck Cancers. Frontiers in Oncology 11.
Crossref
Huizhen Wang, Yida Lu, Mingliang Wang, Youliang Wu, Xiaodong Wang & Yongxiang Li. (2021) Roles of E3 ubiquitin ligases in gastric cancer carcinogenesis and their effects on cisplatin resistance. Journal of Molecular Medicine 99:2, pages 193-212.
Crossref
Zhi-wei Wang, Xiaoli Hu, Miaomiao Ye, Min Lin, Man Chu & Xian Shen. (2020) NEDD4 E3 ligase: Functions and mechanism in human cancer. Seminars in Cancer Biology 67, pages 92-101.
Crossref
Dennis Poel, François Rustenburg, Daoud Sie, Hendrik F. van Essen, Paul P. Eijk, Elisabeth Bloemena, Teresita Elhorst Benites, Madeleine C. van den Berg, Marije R. Vergeer, René C. Leemans, Tineke E. Buffart, Bauke Ylstra, Ruud H. Brakenhoff, Henk M. Verheul & Jens Voortman. (2020) Expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer. Oral Oncology 109, pages 104851.
Crossref
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, Mahshad Kalantari, Reza Mohammadinejad, Tahereh Javaheri & Gautam Sethi. (2020) Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance. International Journal of Molecular Sciences 21:11, pages 4002.
Crossref
Xinfang Yu, Ruike Wang, Yangnan Zhang, Li Zhou, Wei Wang, Haidan Liu & Wei Li. (2019) Skp2-mediated ubiquitination and mitochondrial localization of Akt drive tumor growth and chemoresistance to cisplatin. Oncogene 38:50, pages 7457-7472.
Crossref
Ying‐Juan Zheng, Jing‐Yi Zhao, Tian‐Song Liang, Ping Wang, Juan Wang, Dao‐Ke Yang & Zhang‐Suo Liu. (2019) Long noncoding RNA SMAD5‐AS1 acts as a microRNA‐106a‐5p sponge to promote epithelial mesenchymal transition in nasopharyngeal carcinoma. The FASEB Journal 33:11, pages 12915-12928.
Crossref
Xia Ma, Bei Wang, Xiaofang Wang, Yujiao Luo & Wufang Fan. (2018) NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells. PLOS ONE 13:4, pages e0192436.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.